JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

A contemporary review of endoscopic sinus surgery: techniques, tools, and outcomes.

Laryngoscope 2009 November
Chronic rhinosinusitis is estimated to nearly 25 million people annually in the United States alone. The medical management of these patients is often successful; however, when medical management fails, surgery may be indicated to bring relief. Unfortunately, surgery for chronic rhinosinusitis is not standardized and we remain without a consensus on both the extent of surgery required and the manner in which it is performed. In the past 25 years, three philosophies or schools of thought have arisen to help guide the surgical treatment of chronic rhinosinusitis. Functional endoscopic sinus surgery aims to surgically treat problem areas by ventilating the sinuses through the natural ostia and addressing all diseased sinuses when necessary. This procedure is not standardized and is patient and surgeon dependent. The minimally invasive sinus technique has been proposed as a method whereby each surgical procedure is standardized regardless of disease severity. Lastly, balloon catheter dilatation of the sinus ostia, which by itself is not truly a procedure, is also discussed as a separate philosophy since these specific tools used during endoscopic sinus surgery have quickly energized the sinus community. All three schools of thought possess benefits and drawbacks, even when used appropriately. The concepts, tools, and technologies will be reviewed here as well as outcomes in the hopes that this article will provide an understanding of the surgical options to successfully treat chronic rhinosinusitis.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app